Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/1994
06/22/1994CA2112027A1 Prostaglandin combinations in glaucoma therapy
06/21/1994US5322850 Antiallergic piperidine derivatives of benzimidazole
06/18/1994CA2111644A1 Use of thrombin inhibitors for the inhibition of ocular fibrin formation
06/17/1994CA2111362A1 Imidazopyridines
06/15/1994CA2111302A1 3-(6-quinolylmethyl)-4h-imidazol-4-one derivatives, their preparation and their application in therapy
06/14/1994US5321039 Method of inducing a histamine agonist action on H2 receptors
06/14/1994US5321017 Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss
06/14/1994US5320841 Vision disorders, ophthalmology
06/09/1994WO1994012488A1 Nitroxy compounds with pharmaceutical properties
06/09/1994WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them
06/09/1994WO1993012093A1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
06/08/1994EP0517789B1 Inhibitor of proliferation of endothelial cells
06/01/1994EP0577646A4 Sustained release drug delivery devices
05/1994
05/26/1994WO1994011342A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
05/26/1994CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
05/25/1994EP0597968A1 New leukotriene-b 4? antagonists, methods of preparing them and their use as drugs
05/25/1994EP0358660B1 Synthetic inhibitors of mammalian collagenase
05/24/1994US5314880 Benzimidazole derivatives
05/24/1994US5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
05/17/1994US5312832 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
05/17/1994CA1329620C Ethynylphenyl-containing retinoic acid derivatives
05/11/1994WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen
05/11/1994WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
05/11/1994WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
05/11/1994WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
05/11/1994WO1994009794A1 Ophthalmic solution and method of use
05/11/1994WO1994009761A1 Stable extended release oral dosage composition
05/11/1994CA2148108A1 Ophthalmic solution and method of use
05/11/1994CA2136076A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
05/10/1994US5310743 1-acylpiperidine compounds
05/05/1994DE4335366A1 Verfahren zur Herstellung eines kristallinen Typ A Botulinum Toxins als therapeutische Arznei A process for preparing a crystalline botulinum toxin type A as a therapeutic drug
05/04/1994EP0595769A1 Method of disinfecting a contact lens and preserving a contact lens care solution
05/04/1994EP0595610A1 Benzo-fused lactams
05/04/1994EP0410006B1 Eye drops for healing wound of corneal epithelium
05/04/1994CN1086214A Di-and triazinediones
05/04/1994CN1086132A Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure
05/03/1994US5308863 Substituted aromatic sulfonamides as antiglaucoma agents
05/03/1994US5308849 Ajmaline
05/03/1994US5308846 Vision defects, hypotensive agents
05/03/1994US5308842 Ocular hypotensive agents; glaucoma
05/03/1994US5308624 Ophthalmic product
04/1994
04/29/1994CA2107443A1 Benzo-fused lactams
04/28/1994WO1994008990A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
04/28/1994WO1994008602A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
04/28/1994WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
04/28/1994WO1994008587A1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
04/28/1994WO1994008585A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
04/28/1994CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof
04/28/1994CA2143193A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
04/28/1994CA2126093A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
04/27/1994EP0593520A1 Ocular compositions containing steroids and their use in treating glaucoma
04/27/1994CN1085899A 7-(2-aminoethyl)-benzothiazolones
04/27/1994CN1085897A Angiotension II antagonists
04/27/1994CA2109019A1 Method of disinfecting a contact lens and preserving a contact lens care solution
04/26/1994US5306731 Method and products for treating the eye
04/19/1994US5304569 Compositions and their use in lowering intraocular pressure
04/19/1994US5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion
04/19/1994US5304557 Substituted oxoophthalazinyl acetic acids and analogs thereof
04/19/1994US5304552 Renin inhibitors
04/19/1994CA1328665C Lacrimal secretion stimulant (lss)
04/19/1994CA1328614C Preservative system for ophthalmics formulations
04/19/1994CA1328608C Glaucoma treatment
04/19/1994CA1328605C Medicinal composition useful for the treatment of dermatological diseases
04/14/1994WO1994007867A1 Substituted pyrimidines for control of diabetic complications
04/13/1994EP0591891A2 Benzimidazole derivatives as Angiotensin II antagonists
04/13/1994CN1085082A Vitamin E drop
04/07/1994CA2107604A1 Benzimidazole, pharmaceutical compositions containing these compounds and processes for preparing them
04/06/1994EP0590972A1 Treatment of ocular hypertension with a synergistic combination
04/06/1994EP0590789A1 Excitatory amino acid receptor antagonists
04/06/1994EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions
04/06/1994EP0590549A1 Process for preparing thienothiopyran derivative
04/06/1994EP0590152A1 Peptides with tachykinin antagonist activity
04/05/1994US5300674 Antiarthritic, antitumor agents; for osteoporosis, corneal ulceration
04/05/1994US5300504 Increasing renal fluid flow
04/05/1994CA1328263C Substituted thieno[2,3-b]furan-2-sulfonamides as antiglaucoma agents
04/05/1994CA1328262C Substituted aromatic sulfonamides as antiglaucoma agents
04/05/1994CA1328261C Thiophene sulfonamide antiglaucoma agents
03/1994
03/31/1994WO1994006433A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
03/31/1994WO1994006411A1 Topical carbonic anhydrase inhibitor composition
03/31/1994CA2141879A1 Topical carbonic anhydrase inhibitor composition
03/30/1994EP0589703A1 Proline derivative of rapamycin, production and application thereof
03/30/1994EP0589201A1 Di- and triazindeones
03/29/1994US5298505 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
03/29/1994US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI
03/29/1994CA1328106C Anticholinergic compounds, pharmaceutical compositions and method of treatment
03/29/1994CA1328075C Ocular hypotensive agents
03/25/1994CA2106034A1 21-norrapamycin
03/23/1994EP0587698A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
03/23/1994CN1084079A Ophthalmic compositions
03/22/1994US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium
03/22/1994US5296486 Leukotriene biosynthesis inhibitors
03/22/1994US5296472 Methods for delipidation of skin and cerumen removal
03/17/1994WO1994005674A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds
03/17/1994WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
03/17/1994WO1994005274A1 Glycation inhibitor
03/17/1994WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
03/17/1994WO1993025530A3 Vinyl arenas having retinoid-like activity
03/17/1994CA2141965A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds
03/16/1994EP0587264A1 Aqueous pharmaceutical formulations of sodium cromoglycate
03/16/1994EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents